Clinical Trials Logo

Clinical Trial Summary

Moyamoya Disease(MMD), also known as spontaneous basilar artery occlusion, is characterized by the gradual thickening of arterial intima at the distal carotid artery and the proximal portion of anterior/middle cerebral artery, the gradual stenosis or occlusion of arterial lumen, and the compensatory expansion of basilar cerebral perforating arteries. Cerebral infarction and cerebral hemorrhage are common clinical symptoms of MMD with high morbidity of disability. For ischemic moyamoya disease, intracranial/extracranial revascularization is the preferred treatment. However, for patients with hemorrhagic moyamoya disease, there is controversy about whether to have surgical treatment, the timing and the method of surgical treatment, and the effect of surgical treatment to prevent rebleeding due to the lack of large sample, multi-center, prospective randomized studies. At present, the studies on the effect of revascularization and conservative treatment on hemorrhagic moyamoya disease are retrospective case analyses without randomized control. The sample size of these studies are small, and the conclusions obtained are inconsistent. Due to the differences in the epidemiology and episode type of moyamoya disease in different countries, there is no prospective, randomized controlled study of blood type moyamoya disease in China to confirm the efficacy of revascularization and lack of uniform norms and standards.


Clinical Trial Description

Objective: The aim of this study is to perform a prospective, randomized study on hemorrhagic moyamoya disease to confirm the effect of revascularization in China, and to establish specifications and standards to guide the treatment options for hemorrhagic moyamoya disease as well.

Design: This study is a single-center study and plan to include 108 patients. According to a random number table, hemorrhagic moyamoya patients will be assigned to three groups: conservative treatment group, direct revascularization group and indirect revascularization group. A prospective, randomized study will be carried out to evaluate the effect of revascularization and conservative treatment on the reduction of rebleeding risk and improvement of ischemia in adult patients with hemorrhagic moyamoya disease.

Observation Measures: 1.Rebleeding; 2.Cerebral infarction resulting in severe disability (mRS scoreā‰„3); 3.Severe disability or death caused by other reasons; 4. Patients in conservative treatment group need revascularization due to progressive ischemic stroke or progressive Transient ischemic attack(TIA). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03627975
Study type Interventional
Source Affiliated Hospital to Academy of Military Medical Sciences
Contact Lian Duan, Chief
Phone 0086-10-66947156
Email keyan307@163.com
Status Recruiting
Phase N/A
Start date October 1, 2017
Completion date October 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT03785171 - Predicative Value of Multimodal MRI in Moyamoya Disease
Recruiting NCT05619068 - The Evolution and Prognosis of Moyamoya Disease
Recruiting NCT03613701 - Relationship Between Endothelial Progenitor Cells and Revascularization Effect of Moyamoya Disease
Recruiting NCT06041659 - Functional Magnetic Resonance-Based Observations of Brain Networks in Moyamoya Disease Patients Under Anesthesia
Not yet recruiting NCT06051552 - Prognostic Prediction Model in Patients With Moyamoya Disease Undergoing Revascularization Surgery
Suspended NCT04064658 - Effects of Remote Ischemic Pre-Conditioning in Moyamoya Disease Patients N/A
Not yet recruiting NCT06330818 - Imaging in Moyamoya Disease - Study to Investigate Different Imaging Technologies for a Better Understanding of Various Imaging Techniques to Evaluate Cerebral Hemodynamics, Disease-activity and Possibly the Etiology in Moyamoya Patients N/A
Recruiting NCT05332756 - Long-term Outcomes of Conservative Management in Patients With Moyamoya Disease and Their First-degree Relatives (LAMORA)
Recruiting NCT04890782 - Gut Microbiota in Patients With Moyamoya Disease
Completed NCT03162588 - Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya Phase 1/Phase 2
Completed NCT03072914 - Effects of Remote Ischemic Preconditioning With Postconditioning on Neurologic Outcome N/A
Recruiting NCT02305407 - Neurocognitive and Radiological Assessments in Adult Moyamoya Undergoing Surgery N/A
Recruiting NCT04917003 - Safety and Efficacy of Remote Ischemic Conditioning Combined EDAS on Ischemic Moyamoya Disease N/A
Completed NCT04012268 - The Safety and Efficacy of RIC on Adult Moyamoya Disease N/A
Not yet recruiting NCT04205578 - NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events Phase 3
Recruiting NCT02982135 - Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease N/A
Recruiting NCT02074111 - Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke N/A
Recruiting NCT04696094 - The Role of m6A RNA Modification in Moyamoya Disease
Completed NCT04906564 - RNF213 Variants and Collateral Vessels in Moyamoya Disease
Recruiting NCT05961748 - Registry of Multicenter Brain-Heart Comorbidity in China